|
Volumn 24, Issue 5, 2011, Pages 447-451
|
Asenapine: A new antipsychotic option
|
Author keywords
asenapine; atypical antipsychotic; bipolar disorder; Saphris; schizophrenia
|
Indexed keywords
ALPHA 1 ADRENERGIC RECEPTOR;
ALPHA 2 ADRENERGIC RECEPTOR;
ASENAPINE;
DOPAMINE 1 RECEPTOR;
DOPAMINE 2 RECEPTOR;
DOPAMINE 3 RECEPTOR;
DOPAMINE 4 RECEPTOR;
HALOPERIDOL;
HISTAMINE H1 RECEPTOR;
HISTAMINE H2 RECEPTOR;
ILOPERIDONE;
LITHIUM;
MUSCARINIC RECEPTOR;
OLANZAPINE;
PLACEBO;
RISPERIDONE;
SEROTONIN 1A RECEPTOR;
SEROTONIN 1B RECEPTOR;
SEROTONIN 2A RECEPTOR;
SEROTONIN 2B RECEPTOR;
SEROTONIN 2C RECEPTOR;
SEROTONIN 5 RECEPTOR;
SEROTONIN 6 RECEPTOR;
SEROTONIN 7 RECEPTOR;
VALPROIC ACID;
WATER;
AKATHISIA;
ANTICHOLINERGIC SYNDROME;
AREA UNDER THE CURVE;
ARTICLE;
BINDING AFFINITY;
BIPOLAR I DISORDER;
COST BENEFIT ANALYSIS;
DIABETES MELLITUS;
DIZZINESS;
DRUG ADSORPTION;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG LABELING;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG TOLERABILITY;
EXTRAPYRAMIDAL SYMPTOM;
FOOD DRUG INTERACTION;
FOOD INTAKE;
HUMAN;
HYPESTHESIA;
LIVER DYSFUNCTION;
PATIENT COMPLIANCE;
POSITIVE AND NEGATIVE SYNDROME SCALE;
QT PROLONGATION;
RECOMMENDED DRUG DOSE;
SCHIZOPHRENIA;
SEDATION;
SIDE EFFECT;
SINGLE DRUG DOSE;
SOMNOLENCE;
TABLET FORMULATION;
WEIGHT GAIN;
|
EID: 83455186909
PISSN: 08971900
EISSN: 15311937
Source Type: Journal
DOI: 10.1177/0897190011422875 Document Type: Article |
Times cited : (5)
|
References (11)
|